Physician profile
Daniel B Sims
NPI 1548283112
$8,312.20
in general payments reported to CMS, 2019-2025
17 companies · $3,145 in 2025
The $3,145 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,560 · 2020: $289 · 2021: $15.89 · 2022: $342 · 2023: $239 · 2024: $2,721 · 2025: $3,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,000 · Food and Beverage: $2,016 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,000.00 |
| Food and Beverage | $2,016.27 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,045.66 | 2019-2025 | Lifevest |
| Abbott Laboratories | $2,056.34 | 2019-2025 | Mitraclip |
| Abiomed | $428.09 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $300.14 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $221.24 | 2023-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $192.31 | 2023-2025 | Opsumit, Uptravi |
| Pfizer INC. | $176.14 | 2021-2025 | |
| Scpharmaceuticals INC. | $161.58 | 2023-2025 | |
| Celgene Corporation | $152.42 | 2023-2025 | Camzyos |
| Cvrx, INC. | $152.04 | 2023-2025 | Barostim Neo System |
| Janssen Biotech, INC. | $95.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $85.91 | 2024-2025 | Eliquis, Camzyos |
| Daiichi Sankyo INC. | $84.63 | 2025 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $78.60 | 2023-2025 | Livtencity |
| Astrazeneca Pharmaceuticals Lp | $43.49 | 2025 | Wainua |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $20.63 | 2023 | Zio Xt Patch |
| Amgen INC. | $17.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.